Security key
86150R107
Stoke Therapeutics, Inc. - COMMON STOCK (STOK)
CUSIP: 86150R107
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 54,138,461
- Total 13F value
- $730,867,238
- Share change
- +9,100,250
- Put/Call ratio
- 183%
- SEC-reported price per share
- $13.50
- Number of holders
- 101
- Value change
- +$123,726,512
- Number of buys
- 65
- Number of sells
- 34
- Shares outstanding
- 62,507,059
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
101
Top holders
10
STOK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - Stoke Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Skorpios Trust
Disclosed value leader
Skorpios Trust
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 23%
Showing 1-6 of 15 holder rows.
Quick read
Skorpios Trust leads the comparable SEC ownership view at 23%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Skorpios Trust's linked filing trail.
Comparable ownership
Top 5
Skorpios Trust
23%
RTW INVESTMENTS, LP
6.6%
COWEN AND COMPANY, LLC
6%
MORGAN STANLEY
5.4%
Lynx1 Capital Management LP
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Skorpios Trust |
13F
Company
|
23%
|
$75,973,762
14,443,681 shares
|
— | 31 Dec 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
6.6%
|
$21,729,297
4,131,045 shares
|
— | 31 Dec 2023 |
| COWEN AND COMPANY, LLC |
13F
Company
|
6%
|
$19,575,926
3,721,659 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
5.4%
|
$17,728,104
3,370,362 shares
|
— | 31 Dec 2023 |
| Lynx1 Capital Management LP |
13F
Company
|
4.7%
|
$15,553,389
2,956,918 shares
|
— | 31 Dec 2023 |
| Redmile Group, LLC |
13F
Company
|
4.2%
|
$13,810,162
2,625,506 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
101
Shares
54,138,461
Rows available
101
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
101
Q1 2024 holders
101
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend